Trial Profile
A Study of Golimumab (CNTO 148) Administered in Combination With Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Golimumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms GO-FORTH
- Sponsors Janssen Pharmaceutical KK
- 08 Apr 2023 As per NCT main page the collaborator is "Mitsubishi Tanabe Pharma Corporation" but according to compare view it is showing as "Mitsubishi Tanabe Pharma America" and I am keeping the associations as per NCT.
- 26 Jun 2012 Actual patient number changed from 276 to 269 to as reported by ClinicalTrials.gov.
- 09 Jun 2012 Results presented at the 13th Annual Congress of the European League Against Rheumatism.